LAST month a new iteration of Juicy Fields, dubbed Juicy Fields DAO (Decentralised Autonomous Organisation), contacted BusinessCann directly to inform us of a supposed...
Intercure
Israel’s largest cannabis company, Intercure, saw its stock fall around 10% this week as it became involved in a legal dispute with Cann Pharmaceuticals,...
WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future.
However, one UK company -...
MALTA’s Authority for the Responsible Use of Cannabis (ARUC) has said that it plans to significantly reduce financially prohibitive licence fees for cannabis associations.
Earlier...
FRANCE’s ongoing medical cannabis ‘experiment’, in which 3,000 patients are offered free products, has reported an overwhelmingly positive patient response.
According to the first clinical...
IN November 2022, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) released new detailed guidelines for medical cannabis companies operating in the UK,...
Love Hemp
BusinessCann has learned that the embattled CBD retailer Love Hemp has officially called in administrators.
In a statement published on its website yesterday evening,...
YESTERDAY morning Cellular Goods informed investors that its proposed £18.6m reverse-takeover deal with Cannaray has been scrapped.
In a brief RNS, the CBD retailer said...
LOVE Hemp has responded to damning allegations made publicly by its former managing director Philip Small, who left the company in November 2022.
The Aquis-listed...
THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms of gambling, alcohol and tobacco.
On...
Akanda
Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not seen since October.
The NASDAQ-listed medical...
After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global governance, explain Lorenza Romanese, Managing...
AT the end of 2022 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) held its first ‘technical expert meeting’ on hexahydrocannabinol, better...
Oxford Cannabinoid Technologies
THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the first significant growth in its...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...